TCR² Therapeutics to Participate in Two Upcoming Conferences in March
CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline...
Month: March 2021
Cidara Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm modelCALGARY, Alberta, March 03, 2021 (GLOBE NEWSWIRE)...
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing
VANCOUVER, March 03, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...
MiMedx to Participate at Upcoming Investor Conferences
MARIETTA, Ga., March 03, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
89bio to Participate in the H.C. Wainwright Global Life Sciences Conference
SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
Topline data from two ongoing COVID-19 studies with KB109 expected in Q1 2021 KB295 study in patients with ulcerative colitis...
Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies announced today the appointment of Mark D. Angelino, co-founder and...
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference
WEST CHESTER, Pa., March 03, 2021 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing...
G1 Therapeutics to Participate in Two Investor Conferences in March
RESEARCH TRIANGLE PARK, N.C., March 03, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...
InflaRx to Present at Upcoming Investor Conferences
InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced that management...
Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update
~ Submitted New Drug Application (NDA) for RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome to U.S. Food &...
Repligen Corporation to Present at Barclays Global Healthcare Conference
WALTHAM, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,...
Plus Therapeutics to Participate in Upcoming Virtual Conferences
AUSTIN, Texas, March 03, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel,...
Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in the U.S.
Transaction Furthers Kamada’s Strategic Objective to Evolve into a Fully Integrated Specialty Plasma Company Kamada is Already Actively Engaged in...
Product and Regulatory Update on MedMira’s COVID-19 Product Family
HALIFAX, Nova Scotia, March 03, 2021 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its product...
Prelude Therapeutics Announces Participation at Three Upcoming Virtual Investor Conferences
WILMINGTON, Del., March 03, 2021 (GLOBE NEWSWIRE) -- Prelude Therapeutics Inc. (“Prelude”, “the Company”, “we”, “our”) (Nasdaq: PRLD), a clinical-stage...
Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors
TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops...
Viemed Healthcare Announces Record 2020 Financial Results
LAFAYETTE, La., March 03, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a...
Even Before COVID-19, 24% Reported Putting off Their Colonoscopy
Olympus Surveys Patient Perceptions on Colorectal Cancer and Other Minimally Invasive Procedures CENTER VALLEY, Pa.--(BUSINESS WIRE)--Olympus announced today its findings...